301 related articles for article (PubMed ID: 14576476)
1. Immunoprofile of ovarian tumors with putative transitional cell (urothelial) differentiation using novel urothelial markers: histogenetic and diagnostic implications.
Logani S; Oliva E; Amin MB; Folpe AL; Cohen C; Young RH
Am J Surg Pathol; 2003 Nov; 27(11):1434-41. PubMed ID: 14576476
[TBL] [Abstract][Full Text] [Related]
2. Potential utility of uroplakin III, thrombomodulin, high molecular weight cytokeratin, and cytokeratin 20 in noninvasive, invasive, and metastatic urothelial (transitional cell) carcinomas.
Parker DC; Folpe AL; Bell J; Oliva E; Young RH; Cohen C; Amin MB
Am J Surg Pathol; 2003 Jan; 27(1):1-10. PubMed ID: 12502922
[TBL] [Abstract][Full Text] [Related]
3. Brenner tumors but not transitional cell carcinomas of the ovary show urothelial differentiation: immunohistochemical staining of urothelial markers, including cytokeratins and uroplakins.
Riedel I; Czernobilsky B; Lifschitz-Mercer B; Roth LM; Wu XR; Sun TT; Moll R
Virchows Arch; 2001 Feb; 438(2):181-91. PubMed ID: 11253121
[TBL] [Abstract][Full Text] [Related]
4. [Clinicopathologic features observation of ovarian transitional cell tumors].
Wang L; Dong Y; Li Q; Li H; Sun X; Zhou X; Li X
Zhonghua Bing Li Xue Za Zhi; 2015 Feb; 44(2):118-22. PubMed ID: 25916643
[TBL] [Abstract][Full Text] [Related]
5. Ovarian transitional cell carcinoma represents a poorly differentiated form of high-grade serous or endometrioid adenocarcinoma.
Takeuchi T; Ohishi Y; Imamura H; Aman M; Shida K; Kobayashi H; Kato K; Oda Y
Am J Surg Pathol; 2013 Jul; 37(7):1091-9. PubMed ID: 23681072
[TBL] [Abstract][Full Text] [Related]
6. Transitional cell carcinoma of the ovary is related to high-grade serous carcinoma and is distinct from malignant brenner tumor.
Ali RH; Seidman JD; Luk M; Kalloger S; Gilks CB
Int J Gynecol Pathol; 2012 Nov; 31(6):499-506. PubMed ID: 23018212
[TBL] [Abstract][Full Text] [Related]
7. Expression of the urothelial differentiation markers GATA3 and placental S100 (S100P) in female genital tract transitional cell proliferations.
Esheba GE; Longacre TA; Atkins KA; Higgins JP
Am J Surg Pathol; 2009 Mar; 33(3):347-53. PubMed ID: 19092634
[TBL] [Abstract][Full Text] [Related]
8. Transitional cell tumors of the ovary: a compact group with a heterogeneous histological and immunophenotypical pattern.
Ceauşu M; Terzea D; Georgescu A; Dobrea C; Mihai M; Iosif C; Vasilescu F; Ardeleanu C
Rom J Morphol Embryol; 2008; 49(4):513-6. PubMed ID: 19050800
[TBL] [Abstract][Full Text] [Related]
9. Clear cell carcinoma of the urinary bladder: a report and comparison of four tumors of mullerian origin and nine of probable urothelial origin with discussion of histogenesis and diagnostic problems.
Oliva E; Amin MB; Jimenez R; Young RH
Am J Surg Pathol; 2002 Feb; 26(2):190-7. PubMed ID: 11812940
[TBL] [Abstract][Full Text] [Related]
10. Transitional cell tumors of the ovary: a comparative clinicopathologic, immunohistochemical, and molecular genetic analysis of Brenner tumors and transitional cell carcinomas.
Cuatrecasas M; Catasus L; Palacios J; Prat J
Am J Surg Pathol; 2009 Apr; 33(4):556-67. PubMed ID: 19033864
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological features and immunoprofile of 30 cases of Brenner ovarian tumors.
Kondi-Pafiti A; Kairi-Vassilatou E; Iavazzo Ch; Vouza E; Mavrigiannaki P; Kleanthis Ch; Vlahodimitropoulos D; Liapis A
Arch Gynecol Obstet; 2012 Jun; 285(6):1699-702. PubMed ID: 22198845
[TBL] [Abstract][Full Text] [Related]
12. Malignant Brenner tumor and transitional cell carcinoma of the ovary: a comparison.
Austin RM; Norris HJ
Int J Gynecol Pathol; 1987; 6(1):29-39. PubMed ID: 3570630
[TBL] [Abstract][Full Text] [Related]
13. Recurrent urothelial carcinoma-like FGFR3 genomic alterations in malignant Brenner tumors of the ovary.
Lin DI; Killian JK; Venstrom JM; Ramkissoon SH; Ross JS; Elvin JA
Mod Pathol; 2021 May; 34(5):983-993. PubMed ID: 33077920
[TBL] [Abstract][Full Text] [Related]
14. [Transitional cell carcinoma of the ovary. Morphological and clinical features].
Kommoss F; Kommoss S; Eichhorn J; Schmidt D
Pathologe; 2007 May; 28(3):209-14. PubMed ID: 17447068
[TBL] [Abstract][Full Text] [Related]
15. Ovarian mucinous tumors associated with mature cystic teratomas: morphologic and immunohistochemical analysis identifies a subset of potential teratomatous origin that shares features of lower gastrointestinal tract mucinous tumors more commonly encountered as secondary tumors in the ovary.
Vang R; Gown AM; Zhao C; Barry TS; Isacson C; Richardson MS; Ronnett BM
Am J Surg Pathol; 2007 Jun; 31(6):854-69. PubMed ID: 17527072
[TBL] [Abstract][Full Text] [Related]
16. Transitional cell neoplasms of the ovary and urinary bladder: a comparative immunohistochemical analysis.
Soslow RA; Rouse RV; Hendrickson MR; Silva EG; Longacre TA
Int J Gynecol Pathol; 1996 Jul; 15(3):257-65. PubMed ID: 8811388
[TBL] [Abstract][Full Text] [Related]
17. p63 expression in ovarian tumours: a marker for Brenner tumours but not transitional cell carcinomas.
Liao XY; Xue WC; Shen DH; Ngan HY; Siu MK; Cheung AN
Histopathology; 2007 Oct; 51(4):477-83. PubMed ID: 17880529
[TBL] [Abstract][Full Text] [Related]
18. Transitional cell carcinoma of the ovary: a morphologic study of 100 cases with emphasis on differential diagnosis.
Eichhorn JH; Young RH
Am J Surg Pathol; 2004 Apr; 28(4):453-63. PubMed ID: 15087664
[TBL] [Abstract][Full Text] [Related]
19. [Malignant Brenner tumor and transitional cell carcinoma of the ovary].
Guo LN; Tang MY
Zhonghua Bing Li Xue Za Zhi; 1990 Sep; 19(3):209-11. PubMed ID: 2279315
[TBL] [Abstract][Full Text] [Related]
20. Tubo-Ovarian Transitional Cell Carcinoma and High-grade Serous Carcinoma Show Subtly Different Immunohistochemistry Profiles.
Magrill J; Karnezis AN; Tessier-Cloutier B; Talhouk A; Kommoss S; Cochrane D; Chow C; Cheng A; Soslow R; Hauptmann S; du Bois A; Pfisterer J; Gilks CB; Huntsman DG; Kommoss F
Int J Gynecol Pathol; 2019 Nov; 38(6):552-561. PubMed ID: 30059451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
